Women's Health Innovations for Maternal & Newborn Care
Women's health innovations include medical technologies, diagnostic tools, clinical nutrition, and devices designed to improve maternal and newborn health outcomes throughout pregnancy, childbirth, and the postpartum period. Maternal mortality remains a major public health challenge, particularly in low- and middle-income countries, where adolescent girls aged 15–19 are significantly more likely to experience life-threatening pregnancy and childbirth complications.
Postpartum hemorrhage (PPH) is one of the leading causes of preventable maternal deaths worldwide. Maternova offers evidence-based innovations that support the early detection, measurement, stabilization, and treatment of postpartum hemorrhage, including the Non-Pneumatic Anti-Shock Garment (NASG) and BT Catheter. Additional solutions focus on the early recognition and management of hypertensive disorders of pregnancy, including preeclampsia, eclampsia, and maternal sepsis.
To support frontline healthcare providers, Maternova distributes the CRADLE Vital Signs Alert (VSA), a pregnancy-specific blood pressure monitor designed for use in low-resource settings. The device enables community health workers, midwives, nurses, and physicians to detect early warning signs of preeclampsia, shock, and sepsis, helping ensure timely referral and treatment.
Every innovation in the Maternova portfolio is carefully evaluated for clinical evidence, durability, affordability, and suitability for resource-constrained healthcare environments. We continuously research hundreds of emerging maternal and newborn health innovations to identify technologies that deliver meaningful impact where they are needed most.
Maternova also simplifies global procurement by helping governments, NGOs, hospitals, and healthcare organizations source maternal health products in bulk through reliable international logistics and supply chain support.
Frequently Asked Questions
What types of women's health products does Maternova offer?
Maternova supplies medical devices, diagnostics, clinical nutrition products, and maternal health technologies that support pregnancy, childbirth, postpartum care, and newborn health, particularly in low-resource settings.
Why is postpartum hemorrhage a major focus?
Postpartum hemorrhage is one of the leading causes of maternal mortality worldwide. Early detection and rapid intervention using evidence-based devices can significantly improve maternal survival.
What is the CRADLE Vital Signs Alert device?
The CRADLE VSA is a pregnancy-specific blood pressure and pulse monitor designed to detect early signs of preeclampsia, sepsis, and shock using a simple traffic-light alert system.
Who are Maternova's products designed for?
Maternova's innovations are used by community health workers, midwives, nurses, physicians, hospitals, humanitarian organizations, NGOs, and government health programs.
Can Maternova products be purchased in bulk?
Yes. Maternova specializes in bulk procurement and international distribution of maternal and newborn health technologies for healthcare systems worldwide.
